Holen Sie sich die Stockscreener-App
64.04
2.01%
1.26
Handel nachbörslich:
64.13
0.09
+0.14%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$62.78
Offen:
$62.91
24-Stunden-Volumen:
13.32M
Relative Volume:
1.37
Marktkapitalisierung:
$81.01B
Einnahmen:
$378.96B
Nettoeinkommen (Verlust:
$5.28B
KGV:
15.28
EPS:
4.19
Netto-Cashflow:
$5.94B
1W Leistung:
+5.28%
1M Leistung:
-1.52%
6M Leistung:
+7.00%
1J Leistung:
+14.28%
1-Tages-Spanne:
$62.18
$64.57
1-Wochen-Bereich:
$60.41
$64.57
52-Wochen-Spanne:
$43.56
$72.51
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Vergleichen Sie CVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
64.04 | 76.95B | 378.96B | 5.28B | 5.94B | 4.19 |
|
UNH
Unitedhealth Group Inc
|
301.91 | 268.12B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
383.84 | 84.11B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
316.64 | 84.41B | 254.47B | 5.03B | 6.01B | 18.06 |
|
HUM
Humana Inc
|
233.13 | 27.15B | 117.76B | 1.21B | 2.39B | 9.95 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
CVS Closing 271 Stores This Year. Here's the Full List So Far - AOL.com
CVS Health Co. (NYSE:CVS) Shares Acquired by Mackenzie Financial Corp - MarketBeat
CVS Health (NYSE:CVS) Trading Up 3.2%What's Next? - MarketBeat
Warren Buffett's Secret Portfolio Was Dumping Walmart and Buying These 2 Stocks Instead - 24/7 Wall St.
CVS and Express Scripts Sue Arkansas Over Restriction on Pharmacy Benefit Managers - Arkansas Business
CVS and Express Scripts sue Arkansas over restriction on pharmacy benefit managers - KY3
CVS (CVS) Challenges Arkansas Law Restricting Pharmacy Ownership - GuruFocus
CVS is closing 270 pharmacies nationwide in blow to shoppersfull list of axed stores - The Mirror US
CVS Health Co. (NYSE:CVS) Shares Sold by Park National Corp OH - MarketBeat
Another Major Pharmacy Chain to Close Hundreds of Stores - parade.com
111 Capital Takes Position in CVS Health Co. (NYSE:CVS) - MarketBeat
NorthCrest Asset Manangement LLC Trims Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Public Employees Retirement System of Ohio Has $27.60 Million Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Twin Lakes Capital Management LLC Sells 12,478 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Michels Family Financial LLC Purchases New Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
Largest pharmacy chain in US closing 271 stores in 2025 – see list - Metro.co.uk
CVS Pharmacy files suit against Arkansas over new law preventing PBM ownership of pharmacies - KARK
Major Pharmacy Chain Announces 270 Closures, What It Means for New Jersey Stores - 92.7 WOBM
American Assets Investment Management LLC Has $2.69 Million Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Buy 5 High Dividend-Paying Giants to Stay Safe Amid Volatile Markets - TradingView
PKO Investment Management Joint Stock Co Takes Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Wealthedge Investment Advisors LLC Buys New Shares in CVS Health Co. (NYSE:CVS) - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Takes $31.37 Million Position in CVS Health Co. (NYSE:CVS) - MarketBeat
B. Riley Wealth Advisors Inc. Decreases Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Denies Reports It Will Close Arkansas Stores Because of New State Law - NTD News
Value Partners Investments Inc. Has $5.06 Million Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
CVS Is Closing Hundreds of Stores By End of Year - Men's Journal
CVS or Cigna: Which Diversified Healthcare Stock Should You Own Now? - The Globe and Mail
CVS Or Cigna: Which Diversified Healthcare Stock Should You Own Now? - Barchart.com
Employees Retirement System of Texas Purchases 39,060 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
4,380 Shares in CVS Health Co. (NYSE:CVS) Bought by Ameriflex Group Inc. - MarketBeat
Leigh Baldwin & CO. LLC Acquires Shares of 6,240 CVS Health Co. (NYSE:CVS) - MarketBeat
Heck Capital Advisors LLC Invests $185,000 in CVS Health Co. (NYSE:CVS) - MarketBeat
Athenahealth names CVS alum as CFO - Yahoo Finance
Toronto Dominion Bank Reduces Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
Novem Group Makes New Investment in CVS Health Co. (NYSE:CVS) - MarketBeat
Vega Investment Solutions Purchases New Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
10,640 Shares in CVS Health Co. (NYSE:CVS) Purchased by Aurdan Capital Management LLC - MarketBeat
Is UnitedHealth the Boeing of Healthcare? Why It May Be Too Big to Break - Investing.com
CVS or DHR: Which Is the Better Value Stock Right Now? - Yahoo Finance
Quantinno Capital Management LP Sells 17,179 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Are Walgreens & CVS Open or Closed on Memorial Day 2025? - Men's Journal
CVS Health Co. (NYSE:CVS) Shares Sold by Two Sigma Advisers LP - MarketBeat
Raiffeisen Bank International AG Takes Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Toronto Dominion Bank Sells 631,920 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Powers Into Medicare & Medicaid with Aggressive Aetna Expansion Strategy; What Lies Ahead? - Smartkarma
Longs Drugs to exit Ward Village location before lease expiration - The Business Journals
CVS Health raises annual profit forecast as turnaround gathers steam - MSN
Court OKs Rite Aid's plan to sell pharmacies to CVS - Healthcare Finance News
Bankruptcy court approves sale of 64 Rite-Aid stores to CVS - Providence Business News
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cvs Health Corp-Aktie (CVS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ROBBINS LARRY | Director |
May 05 '25 |
Sale |
67.41 |
1,323,932 |
89,249,945 |
8,346,799 |
| ROBBINS LARRY | Director |
May 06 '25 |
Sale |
66.67 |
150,000 |
10,000,710 |
8,196,799 |
| Shah Prem S | EVP and Group President |
Mar 17 '25 |
Option Exercise |
62.21 |
846 |
52,630 |
43,190 |
| Clark James David | SVP, Cont & Chief Acct Officer |
Mar 05 '25 |
Option Exercise |
62.21 |
7,513 |
467,384 |
15,907 |
| Clark James David | SVP, Cont & Chief Acct Officer |
Mar 05 '25 |
Sale |
66.35 |
7,513 |
498,488 |
8,394 |
1.47%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):